Study Summary
This trial is testing whether a certain type of blood test can be used to detect early signs of cancer recurrence in people with a certain type of lymphoma.
- Non-Hodgkin's Lymphoma
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 8 Secondary · Reporting Duration: 5 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Baseline PET
1 of 1
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Rituximab Prednisone · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Has the Cyclophosphamide drug been federally approved in the United States?
"Cyclophosphamide was given a score of 2 by our team because, while there is some evidence backing its safety, no Phase 2 trials have been run to test efficacy." - Anonymous Online Contributor
Are patients still being sought for this clinical research?
"That is correct. The clinicaltrials.gov website corroborates that this study, which was established on May 8th, 2019, is still looking for 40 patients at 1 medical facility." - Anonymous Online Contributor
What is the total amount of enrollees in this clinical trial?
"That is correct, the clinical trial indicated on clinicaltrials.gov is currently looking for 40 patients from 1 site. The study was posted on 5/8/2019 and updated recently on 7/8/2022." - Anonymous Online Contributor
What are some of the conditions that Cyclophosphamide has been used to effectively manage?
"While often used to treat lung cancers, Cyclophosphamide can also help patients suffering from small cell lung cancer (sclc), thyroiditis, and polyangium." - Anonymous Online Contributor
Could you list any other research that has been done on Cyclophosphamide?
"As of now, there are 1483 live trials researching Cyclophosphamide with 317 trials in Phase 3. While the majority of the clinical trials for Cyclophosphamide are running out of in Bethesda, Maryland, 51873 other locations across the globe are also conducting research on this medication." - Anonymous Online Contributor